# Vertex Pharmaceuticals Inc / Ma: Form 8-K, filed Jul 5, 2022

- Company: [Vertex Pharmaceuticals Inc / Ma](/companies/vrtx.md) (CIK 875320)
- Form: 8-K
- Filed: 2022-07-05
- Accepted by EDGAR: Jul 5, 2022, 16:08 ET
- Period: 2022-07-01
- Accession: 0000875320-22-000019
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875320/000087532022000019/vrtx-20220701.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875320/000087532022000019/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875320/000087532022000019/vrtx-20220701.htm

Filed Jul 5, 2022.
Source: SEC EDGAR, the filing index for accession 0000875320-22-000019. Last ingested by Listed: Nov 6, 2026, 12:56 ET. No prices; not investment advice.